Education
About Us
Working with TipRanks
Follow Us
PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -57.33K | $ -49.08K | $ -246.39K | $ -176.29K |
| Operating Income | $ -36.32B | $ -43.05M | $ -41.67M | $ -21.44M | $ -14.90M |
| EBITDA | $ -36.32B | $ -40.08M | $ -41.62M | $ -21.19M | $ -14.67M |
| Net Income | $ -39.35B | $ -42.94M | $ -40.85M | $ -16.92M | $ -14.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 41.69B | $ 56.56M | $ 73.82M | $ 65.24M | $ 28.84M |
| Total Assets | $ 45.36B | $ 59.39M | $ 77.01M | $ 67.20M | $ 30.89M |
| Total Debt | $ 12.62B | $ 23.85M | $ 23.47M | $ 490.35K | $ 610.26K |
| Net Debt | $ -29.07B | $ -32.71M | $ -50.35M | $ -64.75M | $ -28.23M |
| Total Liabilities | $ 26.35B | $ 33.26M | $ 33.01M | $ 3.99M | $ 3.76M |
| Stockholders' Equity | $ 19.00B | $ 26.13M | $ 44.00M | $ 63.21M | $ 27.13M |
| Cash Flow | |||||
| Free Cash Flow | $ -35.03B | $ -33.64M | $ -25.71M | $ -12.49M | $ -13.15M |
| Operating Cash Flow | $ -35.03B | $ -33.64M | $ -25.71M | $ -12.49M | $ -13.15M |
| Investing Cash Flow | $ -29.00M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 20.19B | $ 16.38M | $ 34.29M | $ 48.89M | $ 29.83M |